October 2025
1. IRWIN S, van Daelen M, Almaraz I, Park R, et al
   Fidaxomicin Reduces Collagen Expression in Intestinal Fibroblasts Via Platelet-Derived Growth Factor Receptor Beta and Glycogen Synthase Kinase-3 Beta Inhibition.
   Gastroenterology. 2025;169:925-941.
   

   >> Share

   
   
2. BOLTE LA, Bjork JR, Gacesa R, Weersma RK, et al
   Pharmacomicrobiomics: The Role of the Gut Microbiome in Immunomodulation and Cancer Therapy.
   Gastroenterology. 2025;169:813-827.
   

   >> Share

   
   September 2025
3. VAN LIEROP LMA, Devillers MJC, van der Woude CJ, Hoentjen F, et al
   Long-term outcomes of increased versus conventional adalimumab dose interval for patients with Crohn's disease in stable remission: 3-year follow-up of the randomized controlled LADI trial.
   Gastroenterology. 2025 Sep 19:S0016-5085(25)06024.
   

   >> Share

   
   August 2025
4. MOULI VP, Kedia S, Sharma V, Pulimood AB, et al
   Navigating the Differential Diagnosis of Intestinal Tuberculosis and Crohn's Disease.
   Gastroenterology. 2025 Aug 19:S0016-5085(25)05883.
   

   >> Share

   
   
5. KHANNA R, Kuenzig ME
   Global Incidence and Prevalence of Inflammatory Bowel Disease Over Time.
   Gastroenterology. 2025 Aug 5:S0016-5085(25)05854.
   

   >> Share

   
   
6. HUANG S, Pan L, Pang S, Guo H, et al
   Perforin Generated by CD8(+) T Cells Exacerbates Inflammatory Bowel Disease-Induced Depression by Promoting CXCL9 Production in Intestinal Epithelial Cells.
   Gastroenterology. 2025;169:294-307.
   

   >> Share

   
   
7. STIDHAM RW, Ghanem LR, Fletcher JG, Bruining DH, et al
   Artificial Intelligence-Enabled Clinical Trials in Inflammatory Bowel Disease: Automating and Enhancing Disease Assessment and Study Management.
   Gastroenterology. 2025;169:432-443.
   

   >> Share

   
   July 2025
8. LI WAI SUEN CFD, Choy MC, Con D, Cheng K, et al
   Early infliximab levels and clearance predict outcomes after infliximab rescue in acute severe ulcerative colitis: Results from PREDICT-UC.
   Gastroenterology. 2025 Jul 21:S0016-5085(25)05777.
   

   >> Share

   
   
9. BOURGONJE AR, Ibing S, Rajauria P, Peraza J, et al
   Mild Crohn's Disease is Associated with Altered Sphingolipid Metabolism and Reduced Neutrophilic Inflammation.
   Gastroenterology. 2025 Jul 7:S0016-5085(25)05731.
   

   >> Share

   
   
10. REZAZADEH ARDABILI A, Polydorides AD, Colombel JF
    Scrotal swelling in a patient with Crohn's disease: More than meets the eye.
    Gastroenterology. 2025 Jul 2:S0016-5085(25)05728.
    

    >> Share

    
    June 2025
11. BEMELMAN WA, Haanappel AEG, Duijvestein M, van der Does de Willebois EML, et al
    Comments on "Postoperative Endoscopic Outcomes in the MESOCOLIC Trial Investigating Mesenteric-Based Surgery for Crohn's Disease".
    Gastroenterology. 2025 Jun 30:S0016-5085(25)00955.
    

    >> Share

    
    
12. LIU D, Wei Y, Wan J
    Exploring the Role of Wearable Devices in Inflammatory Bowel Disease Management.
    Gastroenterology. 2025 Jun 25:S0016-5085(25)00906.
    

    >> Share

    
    
13. WANG P, Wang J, Zhang P, Xiao W, et al
    Comments on "Preclinical protein signatures of Crohn's disease and ulcerative colitis: A nested case-control study within large population-based cohorts".
    Gastroenterology. 2025 Jun 23:S0016-5085(25)00903.
    

    >> Share

    
    
14. FRUTKOFF YA, Plotkin L, Pollak D, Livovsky J, et al
    Whole food diet induces remission in children and young adults with mild-moderate Crohn's disease and is more tolerable than exclusive enteral nutrition: a randomized controlled trial.
    Gastroenterology. 2025 Jun 17:S0016-5085(25)00896.
    

    >> Share

    
    May 2025
15. HANZEL J, Solitano V, Vuyyuru SK, Panaccione R, et al
    An International Consensus on Appropriate Management of Corticosteroids in Clinical Trials in Inflammatory Bowel Disease.
    Gastroenterology. 2025 May 28:S0016-5085(25)00825.
    

    >> Share

    
    
16. ZHANG Y, Ran Q, Tang X, Wang Y, et al
    Creeping Fat and Muscle Hyperplasia in Crohn's Disease: A Critical Mechanistic Link for Stricture Formation.
    Gastroenterology. 2025 May 2:S0016-5085(25)00665.
    

    >> Share

    
    
17. KELM M, Flemming S
    The importance of the mesentery in the pathophysiology of Crohn's disease.
    Gastroenterology. 2025 May 2:S0016-5085(25)00664.
    

    >> Share

    
    April 2025
18. WU X, Li Y, Li P, Lu G, et al
    Structural variations in ulcerative colitis-associated E. coli reduce fructose utilization and aggravate inflammation under high fructose diet.
    Gastroenterology. 2025 Apr 16:S0016-5085(25)00635.
    

    >> Share

    
    
19. ALLOCCA M, Falloon K, Danese S, Rieder F, et al
    Monitoring the calm before the storm - A video capsule endoscopy guided proactive treat-to-target approach in Crohn's disease.
    Gastroenterology. 2025 Apr 10:S0016-5085(25)00631.
    

    >> Share

    
    
20. MENGHINI P, Butto LF, Gomez-Nguyen A, Aladyshkina N, et al
    TL1A/DR3 signaling regulates the generation of pathogenic Th9 cells in experimental Crohn's disease.
    Gastroenterology. 2025 Apr 7:S0016-5085(25)00606.
    

    >> Share

    
    
21. LIU K, Chen B, Lin X, Zhou Q, et al
    alpha1,3 Fucosyltransferase VII Improves Intestinal Immune Homeostasis in Inflammatory Bowel Disease by Enhancing Regulatory T-Cell Intestinal Homing and Immunosuppression.
    Gastroenterology. 2025 Apr 1:S0016-5085(25)00586.
    

    >> Share

    
    March 2025
22. LI L
    Impact of Parental Crohn's Disease on Offspring's Gut Health and Disease Vulnerability.
    Gastroenterology. 2025 Mar 31:S0016-5085(25)00588.
    

    >> Share

    
    
23. TANG L
    Comments on "Multimodal Profiling of Peripheral Blood Identifies Proliferating Circulating Effector CD4+ T Cells as Predictors for Response to Integrin alpha4beta7-Blocking Therapy in Inflammatory Bowel Disease".
    Gastroenterology. 2025 Mar 28:S0016-5085(25)00545.
    

    >> Share

    
    
24. NARVEY S, Ghia JE, Marrie RA, Armstrong H, et al
    Heavy Metals and Inflammatory Bowel Disease.
    Gastroenterology. 2025 Mar 27:S0016-5085(25)00540.
    

    >> Share

    
    
25. PRENTICE RE, Flanagan EK, Wright EK, Dolinger MT, et al
    Active inflammatory bowel disease on intestinal ultrasound during pregnancy is associated with an increased risk of adverse pregnancy and neonatal outcomes independent of clinical and biochemical disease activity.
    Gastroenterology. 2025 Mar 25:S0016-5085(25)00537.
    

    >> Share

    
    
26. MCDONALD BD, Choi NK, Klein JA, St-Pierre J, et al
    Clinical trials for perianal Crohn's disease: A call for a revised approach.
    Gastroenterology. 2025 Mar 20:S0016-5085(25)00529.
    

    >> Share

    
    
27. HART A, Panaccione R, Steinwurz F, Danese S, et al
    Efficacy and Safety of Guselkumab Subcutaneous Induction and Maintenance in Participants with Moderately to Severely Active Crohn's Disease: Results from the Phase 3 GRAVITI Study.
    Gastroenterology. 2025 Mar 18:S0016-5085(25)00522.
    

    >> Share

    
    
28. BEN-HORIN S, Lahat A, Ungar B, Ukashi O, et al
    Capsule endoscopy-guided proactive treat-to-target versus continued standard care in patients with quiescent Crohn's disease: A randomized controlled trial.
    Gastroenterology. 2025 Mar 13:S0016-5085(25)00519.
    

    >> Share

    
    
29. IACUCCI M, Santacroce G, Maeda Y, Ghosh S, et al
    AI-driven Personalized Medicine: Transforming Clinical Practice in Inflammatory Bowel Disease.
    Gastroenterology. 2025 Mar 10:S0016-5085(25)00494.
    

    >> Share

    
    
30. WANG Y, Zhang C
    Expand Research in Risk of Developing Crohn's Disease.
    Gastroenterology. 2025 Mar 6:S0016-5085(25)00490.
    

    >> Share

    
    
31. YANG X, Hu Q
    Comments on "Healthy first-degree relatives from multiplex families versus simplex families have a higher subclinical intestinal inflammation, a distinct fecal microbial signature, and harbor a higher risk of developing Crohn's disease".
    Gastroenterology. 2025 Mar 6:S0016-5085(25)00489.
    

    >> Share

    
    February 2025
32. NANDY A, Petralia F, Porter C, Elledge S, et al
    Epstein-Barr Virus (EBV) Exposure Precedes Crohn;s Disease Development.
    Gastroenterology. 2025 Feb 21:S0016-5085(25)00411.
    

    >> Share

    
    
33. ABREU MT, Devkota S, Issokson K
    A Mediterranean diet for Crohn's disease: Embracing colorful diversity to improve the microbiome.
    Gastroenterology. 2025 Feb 14:S0016-5085(25)00366.
    

    >> Share

    
    
34. MA C
    Mirikizumab for Crohn's Disease: Small Step Forward or Giant Leap Ahead?
    Gastroenterology. 2025 Feb 4:S0016-5085(25)00344.
    

    >> Share

    
    
35. TURPIN W, Lee SH, Croitoru K
    Gut Microbiome Signature in Predisease Phase of Inflammatory Bowel Disease: Prediction to Pathogenesis to Prevention.
    Gastroenterology. 2025 Feb 3:S0016-5085(25)00039.
    

    >> Share

    
    January 2025
36. KHANNA R
    The safety and efficacy of guselkumab for the treatment of moderate to severely active ulcerative colitis.
    Gastroenterology. 2025 Jan 31:S0016-5085(25)00333.
    

    >> Share

    
    
37. OWEN C, Shen L, Cardoso A, Lichenstein G, et al
    Comments on biologic ranking methodology used by the network meta-analysis to inform the 2024 ulcerative colitis guideline.
    Gastroenterology. 2025 Jan 25:S0016-5085(25)00062.
    

    >> Share

    
    
38. LI L
    Pouch Crohn's-like Disease: Mucosal Single-Cell Profiling Uncovers Pathogenesis and Targets.
    Gastroenterology. 2025 Jan 17:S0016-5085(25)00045.
    

    >> Share

    
    
39. GODNY L, Elial-Fatal S, Arrouasse J, Sharar Fischler T, et al
    Mechanistic implications of the Mediterranean diet in patients with newly diagnosed Crohn's disease- multi-omic results from a prospective cohort.
    Gastroenterology. 2025 Jan 13:S0016-5085(25)00038.
    

    >> Share

    
    
40. DUAN M, Liu W, Coffey JC, Ke J, et al
    Postoperative Endoscopic Outcomes in the MESOCOLIC Trial Investigating Mesenteric-based surgery for Crohn's Disease.
    Gastroenterology. 2025 Jan 9:S0016-5085(25)00017.
    

    >> Share

    
    
41. HIRTEN RP, Danieletto M, Sanchez-Mayor M, Whang JK, et al
    Physiological Data Collected from Wearable Devices Identify and Predict Inflammatory Bowel Disease Flares.
    Gastroenterology. 2025 Jan 9:S0016-5085(25)00013.
    

    >> Share

    
    December 2024
42. COFFEY JC, Bai L, Wu FF
    Catching up with creeping fat - unravelling the mysteries of the mesentery in Crohn's disease.
    Gastroenterology. 2024 Dec 24:S0016-5085(24)05805.
    

    >> Share

    
    
43. LI L
    Comments on "Inflammatory markers at birth and risk of early onset inflammatory bowel disease".
    Gastroenterology. 2024 Dec 20:S0016-5085(24)05797.
    

    >> Share

    
    
44. SHAO X, Chen J, Zhu C, Li J, et al
    Analysis of "Inflammatory Markers at Birth and Risk of Early-Onset Inflammatory Bowel Disease".
    Gastroenterology. 2024 Dec 20:S0016-5085(24)05795.
    

    >> Share

    
    
45. MAO XY, Yang YY, Tian L
    A win-win solution: remarkable reversal of foot necrosis in ulcerative colitis.
    Gastroenterology. 2024 Dec 7:S0016-5085(24)05784.
    

    >> Share

    
    
46. SINGH S, Loftus EV Jr, Limketkai BN, Haydek JP, et al
    AGA Living Clinical Practice Guideline on Pharmacological Management of Moderate-to-Severe Ulcerative Colitis.
    Gastroenterology. 2024;167:1307-1343.
    

    >> Share

    
    
47. DI VINCENZO F, Quintero MA, Mendygral P, Abreu MT, et al
    Gender Inequity in Pharma-Supported Inflammatory Bowel Disease Presentations: Shining a Light on Opportunities for Equality and Transparency in Medical Research.
    Gastroenterology. 2024;167:1256-1259.
    

    >> Share

    
    
48. ZHAO Q, Duck LW, Killian JT Jr, Rosenberg AF, et al
    Crohn's Patients and Healthy Infants Share Immunodominant B Cell Response to Commensal Flagellin Peptide Epitopes.
    Gastroenterology. 2024;167:1415-1428.
    

    >> Share

    
    November 2024
49. GRANNO O, Bergemalm D, Salomon B, Lindqvist CM, et al
    Preclinical protein signatures of Crohn's disease and ulcerative colitis: A nested case-control study within large population-based cohorts.
    Gastroenterology. 2024 Nov 21:S0016-5085(24)05741.
    

    >> Share

    
    
50. KAPPELMAN MD, Brensinger C, Parlett LE, Hurtado-Lorenzo A, et al
    Prevalence of Pediatric Inflammatory Bowel Disease in the United States: Pooled Estimates from Three Administrative Claims Data Sources.
    Gastroenterology. 2024 Nov 16:S0016-5085(24)05698.
    

    >> Share

    
    
51. AGRAWAL M, Ungaro RC, Rajauria P, Magee J, et al
    High serum pesticide levels are associated with increased odds of inflammatory bowel disease in a nested case-control study.
    Gastroenterology. 2024 Nov 9:S0016-5085(24)05692.
    

    >> Share

    
    
52. LIU W, Mao R, Nga Le TH, West G, et al
    CREEPING FAT-DERIVED FREE FATTY ACIDS INDUCE HYPERPLASIA OF INTESTINAL MUSCULARIS PROPRIA MUSCLE CELLS - A NOVEL LINK BETWEEN FAT AND INTESTINAL STRICTURE FORMATION IN CROHN'S DISEASE.
    Gastroenterology. 2024 Nov 8:S0016-5085(24)05659.
    

    >> Share

    
    
53. DORNER H, Stolzer I, Mattner J, Kaminski S, et al
    Gut Pathobiont-Derived Outer Membrane Vesicles Drive Liver Inflammation and Fibrosis in Primary Sclerosing Cholangitis-Associated Inflammatory Bowel Disease.
    Gastroenterology. 2024;167:1183-1197.
    

    >> Share

    
    October 2024
54. JONES K, Plotkin L, Loukogeorgakis S, Cytter-Kuint R, et al
    The management of internal fistulizing Crohn's disease in a child: more than meets the eye.
    Gastroenterology. 2024 Oct 28:S0016-5085(24)05644.
    

    >> Share

    
    
55. ANANTHAKRISHNAN AN, Murad MH, Scott FI, Agrawal M, et al
    Comparative Efficacy of Advanced Therapies for Management of Moderate-to-Severe Ulcerative Colitis: 2024 American Gastroenterological Association Evidence Synthesis.
    Gastroenterology. 2024 Oct 18:S0016-5085(24)05480.
    

    >> Share

    
    
56. SOLITANO V, Hogan M, Singh S, Danese S, et al
    Placebo rates in Crohn's disease randomized clinical trials: An individual patient data meta-analysis.
    Gastroenterology. 2024 Oct 14:S0016-5085(24)05571.
    

    >> Share

    
    
57. LEE SH, Bushra M, Qiu L, Griffiths AM, et al
    Early Life Exposure to Parental Crohn's disease is Associated with Offspring's Gut Microbiome, Gut Permeability and Increased Risk of Future Crohn's Disease.
    Gastroenterology. 2024 Oct 7:S0016-5085(24)05539.
    

    >> Share

    
    
58. CAMILLERI M
    Pouchitis: Is It Time to Think Beyond the Inflammation in the Pouch?
    Gastroenterology. 2024;167:821-825.
    

    >> Share

    
    September 2024
59. HORN V, Cancino CA, Steinheuer LM, Obermayer B, et al
    Multimodal profiling of peripheral blood identifies proliferating circulating effector CD4(+) T cells as predictors for response to integrin alpha4beta7-blocking therapy in inflammatory bowel disease.
    Gastroenterology. 2024 Sep 27:S0016-5085(24)05527.
    

    >> Share

    
    
60. ROSHANOV PS, Khanna R
    Risankizumab for Induction and Maintenance of Remission in Ulcerative Colitis.
    Gastroenterology. 2024 Sep 7:S0016-5085(24)05444.
    

    >> Share

    
    
61. ROSHANOV PS, Khanna R
    A Head-to Head Comparison of Risankizumab and Ustekinumab as second line therapy in moderate to severely active Crohn's disease.
    Gastroenterology. 2024 Sep 7:S0016-5085(24)05445.
    

    >> Share

    
    
62. OLIVERA PA, Martinez-Lozano H, Leibovitzh H, Xue M, et al
    Healthy first-degree relatives from multiplex families versus simplex families have a higher subclinical intestinal inflammation, a distinct fecal microbial signature, and harbor a higher risk of developing Crohn's disease.
    Gastroenterology. 2024 Sep 3:S0016-5085(24)05414.
    

    >> Share

    
    August 2024
63. LU C, Feagan BG, Fletcher JG, Baker M, et al
    Management of Small Bowel Crohn's Disease Strictures: To cut, to stretch or to treat inflammation?
    Gastroenterology. 2024 Aug 31:S0016-5085(24)05413.
    

    >> Share

    
    
64. LEE SH, Turpin W, Espin-Garcia O, Xu W, et al
    Development and Validation of an Integrative Risk Score for Future Risk of Crohn's Disease in Healthy First-Degree Relatives: A Multicentre Prospective Cohort Study.
    Gastroenterology. 2024 Aug 27:S0016-5085(24)05401.
    

    >> Share

    
    
65. KAHN-BOESEL O, Araka E, Anyane-Yeboa A, Ufere NN, et al
    The Discrepant Visual Representation of Inflammatory Bowel Diseases in the Internet and Media.
    Gastroenterology. 2024;167:436-440.
    

    >> Share

    
    
66. LUO X, Wang J, Tan C, Dou Q, et al
    Rapid Endoscopic Diagnosis of Benign Ulcerative Colorectal Diseases With an Artificial Intelligence Contextual Framework.
    Gastroenterology. 2024;167:591-603.
    

    >> Share

    
    July 2024
67. CAO S, Nguyen K, Ma K, Du X, et al
    Mucosal Single-Cell Profiling of Crohn's-Like Disease of the Pouch Reveals Unique Pathogenesis and Therapeutic Targets.
    Gastroenterology. 2024 Jul 29:S0016-5085(24)05284.
    

    >> Share

    
    
68. GAWEY BJ, Kane SV
    Head and Neck Pain in a Patient with Ulcerative Colitis.
    Gastroenterology. 2024 Jul 27:S0016-5085(24)05285.
    

    >> Share

    
    
69. RUDBAEK JJ, Borbye-Lorenzen N, Poulsen GJ, Koziol A, et al
    Inflammatory markers at birth and risk of early onset inflammatory bowel disease.
    Gastroenterology. 2024 Jul 13:S0016-5085(24)05210.
    

    >> Share

    
    
70. MULANAX C, Velayos FS
    Shot heard around the world? Subcutaneous Infliximab (CT-P13) as Maintenance Therapy for Inflammatory Bowel Disease.
    Gastroenterology. 2024 Jul 11:S0016-5085(24)05207.
    

    >> Share

    
    
71. ASHTON JJ, Satsangi J, Uhlig HH
    Intestinal Inflammation and Extraintestinal Disease: Understanding Dynamic Risk.
    Gastroenterology. 2024;167:205-208.
    

    >> Share

    
    June 2024
72. PEDICELLI A, Michel RP, Sebastiani G
    An Unusual Cause of Acute Liver Failure Diagnosed on Organ Explant in a Patient with Ulcerative Colitis.
    Gastroenterology. 2024 Jun 29:S0016-5085(24)05174.
    

    >> Share

    
    
73. BOURGONJE AR, Ungaro RC, Mehandru S, Colombel JF, et al
    Targeting the IL-23 Pathway in Inflammatory Bowel Disease.
    Gastroenterology. 2024 Jun 28:S0016-5085(24)05124.
    

    >> Share

    
    May 2024
74. HANAUER SB, Sands BE, Schreiber S, Danese S, et al
    Subcutaneous Infliximab (CT-P13 SC) as Maintenance Therapy for Inflammatory Bowel Disease: Two Randomized Phase 3 Trials.
    Gastroenterology. 2024 May 22:S0016-5085(24)04918.
    

    >> Share

    
    
75. LUJAN R, Buchuk R, Focht G, Yogev D, et al
    Early Initiation of Biologics and Disease Outcomes in Adults and Children With Inflammatory Bowel Diseases: Results From the Epidemiology Group of the Nationwide Israeli Inflammatory Bowel Disease Research Nucleus Cohort.
    Gastroenterology. 2024;166:815-825.
    

    >> Share

    
    
76. BAMIDELE AO, Mishra SK, Piovezani Ramos G, Hirsova P, et al
    Interleukin 21 Drives a Hypermetabolic State and CD4(+) T-Cell-Associated Pathogenicity in Chronic Intestinal Inflammation.
    Gastroenterology. 2024;166:826-841.
    

    >> Share

    
    April 2024
77. HONAP S, Sands BE, Jairath V, Danese S, et al
    Basket, Umbrella, and Platform Trials: The Potential for Master Protocol -Based Trials in Inflammatory Bowel Disease.
    Gastroenterology. 2024 Apr 25:S0016-5085(24)00485.
    

    >> Share

    
    
78. KEEFER L, Hashash JG, Szigethy E, Mayer EA, et al
    AGA Clinical Practice Update on Pain Management in Inflammatory Bowel Disease: Commentary.
    Gastroenterology. 2024 Apr 17:S0016-5085(24)00358.
    

    >> Share

    
    
79. ZOLLNER A, Koch R, Jukic A, Pfister A, et al
    Clearance of gut mucosal SARS-CoV-2 antigens and post-acute COVID-19 after two years in patients with inflammatory bowel disease.
    Gastroenterology. 2024 Apr 15:S0016-5085(24)00423.
    

    >> Share

    
    March 2024
80. IACUCCI M, Maeda Y, Ghosh S
    A Baby Step or a Real Giant Stride: Histomic Enabled by Artificial Intelligence to Predict Treatment Response in Pediatric Patients with Ulcerative Colitis.
    Gastroenterology. 2024 Mar 7:S0016-5085(24)00284.
    

    >> Share

    
    
81. ZINGONE F, Bai JC, Cellier C, Ludvigsson JF, et al
    Celiac disease-related conditions: Who to test?
    Gastroenterology. 2024 Mar 7:S0016-5085(24)00282.
    

    >> Share

    
    
82. MITEV S, Marinova C, Spassova Z
    A colorful conundrum: dark urine in a patient with inflammatory bowel disease.
    Gastroenterology. 2024 Mar 5:S0016-5085(24)00249.
    

    >> Share

    
    
83. PEERY AF, Kelly CR, Kao D, Vaughn BP, et al
    AGA Clinical Practice Guideline on Fecal Microbiota-Based Therapies for Select Gastrointestinal Diseases.
    Gastroenterology. 2024;166:409-434.
    

    >> Share

    
    
84. DULAI PS, Singh S, Jairath V, Wong E, et al
    Integrating Evidence to Guide Use of Biologics and Small Molecules for Inflammatory Bowel Diseases.
    Gastroenterology. 2024;166:396-408.
    

    >> Share

    
    February 2024
85. KHROM M, Long M, Dube S, Robbins L, et al
    Comprehensive association analyses of extraintestinal manifestations in inflammatory bowel disease.
    Gastroenterology. 2024 Feb 27:S0016-5085(24)00232.
    

    >> Share

    
    
86. HERAUF M, Coward S, Pena-Sanchez JN, Bernstein CN, et al
    A Commentary on the Epidemiology of Inflammatory Bowel Disease in Compounding Prevalence Nations: Towards Sustaining Healthcare Delivery.
    Gastroenterology. 2024 Feb 18:S0016-5085(24)00178.
    

    >> Share

    
    
87. MARILD K, Soderling J, Stephansson O, Axelrad J, et al
    Histological remission in inflammatory bowel disease and female fertility: A nationwide study.
    Gastroenterology. 2024 Feb 6:S0016-5085(24)00055.
    

    >> Share

    
    
88. KOCHAR B, Ananthakrishnan AN, Ritchie CS
    Pharmacoequity for Older Adults With Inflammatory Bowel Diseases.
    Gastroenterology. 2024;166:235-239.
    

    >> Share

    
    
89. HE S, Peng Y, Wei Q
    Comments on "Higher Intra-Abdominal Visceral Adipose Tissue Mass Is Associated With Lower Rates of Clinical and Endoscopic Remission in Patients With Inflammatory Bowel Diseases Initiating Biologic Therapy: Results of the Constellation Study".
    Gastroenterology. 2024;166:356-357.
    

    >> Share

    
    
90. LIU X, Prasath S, Siddiqui I, Walters TD, et al
    Machine Learning-Based Prediction of Pediatric Ulcerative Colitis Treatment Response using Diagnostic Histopathology.
    Gastroenterology. 2024 Feb 1:S0016-5085(24)00119.
    

    >> Share

    
    January 2024
91. HASHASH JG, Elkins J, Lewis JD, Binion DG, et al
    AGA Clinical Practice Update on Diet and Nutritional Therapies in Patients With Inflammatory Bowel Disease: Expert Review.
    Gastroenterology. 2024 Jan 23:S0016-5085(23)05597.
    

    >> Share

    
    
92. KOSINSKY RL, Gonzalez MM, Saul D, Barros LL, et al
    The FOXP3(+) Pro-inflammatory T cell: A Potential Therapeutic Target in Crohn's Disease.
    Gastroenterology. 2024 Jan 9:S0016-5085(24)00009.
    

    >> Share

    
    
93. BARNES EL, Agrawal M, Syal G, Ananthakrishnan AN, et al
    AGA Clinical Practice Guideline on the Management of Pouchitis and Inflammatory Pouch Disorders.
    Gastroenterology. 2024;166:59-85.
    

    >> Share

    
    
94. GILLILAND A, Chan JJ, De Wolfe TJ, Yang H, et al
    Pathobionts in Inflammatory Bowel Disease: Origins, Underlying Mechanisms, and Implications for Clinical Care.
    Gastroenterology. 2024;166:44-58.
    

    >> Share

    
    
95. EQUINOZZI E, O'Donnell M, Lee CD
    A Woman With Pyoderma Gangrenosum, Recurrent Abdominal Pain, and Hematochezia.
    Gastroenterology. 2024;166:31-35.
    

    >> Share

    
    
96. SHEN X, Zhang Q, Zhang B
    A 16-Year-Old Onset Case of Pancolitis With Rectovaginal and Rectovesical Fistulas.
    Gastroenterology. 2024;166:e1-e5.
    

    >> Share

    
    December 2023
97. CAENEPEEL C, Falony G, Machiels K, Verstockt B, et al
    Dysbiosis and associated stool features improve prediction of response to biological therapy in inflammatory bowel disease.
    Gastroenterology. 2023 Dec 12:S0016-5085(23)05598.
    

    >> Share

    
    
98. ANANTHAKRISHNAN AN, Adler J, Chachu KA, Nguyen NH, et al
    AGA Clinical Practice Guideline on the Role of Biomarkers for the Management of Crohn's Disease.
    Gastroenterology. 2023;165:1367-1399.
    

    >> Share

    
    
99. SEGAL JP
    Vedolizumab Earning Its Place as a Treatment for Chronic Pouchitis.
    Gastroenterology. 2023;165:1574-1575.
    

    >> Share

    
    November 2023
100. KOTLARZ DANIEL
     Unveiling the protective role of BTNL-selected gammadelta T cells in inflammatory bowel disease.
     Gastroenterology. 2023 Nov 28:S0016-5085(23)05566.
     

     >> Share

     
     
101. DAVE M, Luther J, Briggs F
     Time to Include Inflammatory Bowel Disease as a Notifiable Disease?
     Gastroenterology. 2023 Nov 7:S0016-5085(23)05223.
     

     >> Share

     
     
102. WINE E
     Could gut and food-derived yeast be responsible for activating T-cells in Crohn disease?
     Gastroenterology. 2023 Nov 3:S0016-5085(23)05204.
     

     >> Share

     
     
103. VENKATESWARAN N
     Mirikizumab for the Management of Ulcerative Colitis.
     Gastroenterology. 2023 Nov 3:S0016-5085(23)05206.
     

     >> Share

     
     October 2023
104. LEE HH, Singh S
     Quantifying Endoscopic Activity in Ulcerative Colitis: Innovation, Powered by AI.
     Gastroenterology. 2023 Oct 30:S0016-5085(23)05201.
     

     >> Share

     
     
105. STIDHAM RW, Cai L, Cheng S, Rajaei F, et al
     Using Computer Vision to Improve Endoscopic Disease Quantification in Therapeutic Clinical Trials of Ulcerative Colitis.
     Gastroenterology. 2023 Oct 11:S0016-5085(23)05086.
     

     >> Share

     
     
106. YARUR AJ, Bruss A, Moosreiner A, Beniwal-Patel P, et al
     Higher Intra-Abdominal Visceral Adipose Tissue Mass Is Associated With Lower Rates of Clinical and Endoscopic Remission in Patients With Inflammatory Bowel Diseases Initiating Biologic Therapy: Results of the Constellation Study.
     Gastroenterology. 2023;165:963-975.
     

     >> Share

     
     September 2023
107. CHEN J, Yang Q, Wang C
     Multiple Hepatic Masses in a Patient with Crohn's disease.
     Gastroenterology. 2023 Sep 20:S0016-5085(23)05014.
     

     >> Share

     
     
108. KHANNA R
     Upadacitinib for the Treatment of Crohn's Disease.
     Gastroenterology. 2023 Sep 13:S0016-5085(23)05001.
     

     >> Share

     
     
109. GANAPATHY A, Navale P, Mutch MG, Kim H, et al
     Long-Standing Symptomatic Fistulizing Perianal Crohn's Disease: Progression beyond inflammation.
     Gastroenterology. 2023 Sep 12:S0016-5085(23)04997.
     

     >> Share

     
     
110. LI Z, Chen Y, Ke H
     Investigating the Causal Relationship between Gut Microbiota and Crohn's Disease: A Mendelian Randomization Study.
     Gastroenterology. 2023 Sep 5:S0016-5085(23)04972.
     

     >> Share

     
     
111. HUANG J, Chan SC, Fung YC, Mak FY, et al
     Incidence, Risk Factors, and Temporal Trends of Small Intestinal Cancer: A Global Analysis of Cancer Registries.
     Gastroenterology. 2023;165:600-612.
     

     >> Share

     
     
112. WINE E
     Pharmacomicrobiomics in IBD: Should We Select Treatments Based on Gut Microbes?
     Gastroenterology. 2023;165:802-803.
     

     >> Share

     
     August 2023
113. PEYRIN-BIROULET L, Allegretti JR, Rubin DT, Bressler B, et al
     Guselkumab in Patients With Moderately to Severely Active Ulcerative Colitis: QUASAR Phase 2b Induction Study.
     Gastroenterology. 2023 Aug 31:S0016-5085(23)04963.
     

     >> Share

     
     
114. LELEIKO NS
     Comment Regarding "Comparative Effectiveness of Anti-TNF in Combination With Low-Dose Methotrexate vs Anti-TNF Monotherapy in Pediatric Crohn's Disease: A Pragmatic Randomized Trial".
     Gastroenterology. 2023 Aug 7:S0016-5085(23)04882.
     

     >> Share

     
     
115. KELM M, Flemming S
     Surgical Resection Might Be the Preferred Therapy Option in Ileocecal Crohn's Disease.
     Gastroenterology. 2023 Aug 4:S0016-5085(23)04840.
     

     >> Share

     
     
116. DAMAS OM, Maldonado-Contreras A
     Breaking Barriers in Dietary Research: Strategies to Diversify Recruitment in Clinical Studies and Develop Culturally Tailored Diets for Hispanic Communities Living With Inflammatory Bowel Disease.
     Gastroenterology. 2023;165:324-328.
     

     >> Share

     
     July 2023
117. MUKHERJEE PK, Nguyen QT, Li J, Zhao S, et al
     Stricturing Crohn's disease single-cell RNA sequencing reveals fibroblast heterogeneity and intercellular interactions.
     Gastroenterology. 2023 Jul 26:S0016-5085(23)04788.
     

     >> Share

     
     
118. LEWIS JD, Parlett LE, Jonsson-Funk ML, Brensinger C, et al
     Incidence, Prevalence and Racial and Ethnic Distribution of Inflammatory Bowel Disease in the United States.
     Gastroenterology. 2023 Jul 15:S0016-5085(23)04776.
     

     >> Share

     
     
119. BAUMDICK ME, Niehrs A, Degenhardt F, Schwerk M, et al
     HLA-DP on Epithelial Cells enables Tissue Damage by NKp44(+) NK Cells in Ulcerative Colitis.
     Gastroenterology. 2023 Jul 14:S0016-5085(23)04772.
     

     >> Share

     
     
120. YAN F, Yang Y
     First line treatment options for ileocecal Crohn's disease: Early surgical resection or Biologics?
     Gastroenterology. 2023 Jul 3:S0016-5085(23)00933.
     

     >> Share

     
     
121. DEEPAK P, Barnes EL, Shaukat A
     Health Disparities in Inflammatory Bowel Disease Care Driven by Rural Versus Urban Residence: Challenges and Potential Solutions.
     Gastroenterology. 2023;165:11-15.
     

     >> Share

     
     
122. GHUSN W, Acosta A, Kane S
     An Unusual Etiology of Bleeding in an Inflammatory Bowel Disease Surveillance Colonoscopy.
     Gastroenterology. 2023;165:40-43.
     

     >> Share

     
     June 2023
123. GAO S, Zhu R, Zhu L
     Toward the understanding of altered gut microbiome in Crohn's disease: cause or consequence.
     Gastroenterology. 2023 Jun 23:S0016-5085(23)00883.
     

     >> Share

     
     
124. AGRAWAL M, Ebert AC, Poulsen G, Ungaro RC, et al
     Early ileocecal resection for Crohn's disease is associated with improved long-term outcomes compared to anti-tumor necrosis factor therapy: a population-based cohort study.
     Gastroenterology. 2023 Jun 9:S0016-5085(23)00872.
     

     >> Share

     
     
125. HE S, Lei P, Kang W, Cheung P, et al
     Stiffness Restricts the Stemness of the Intestinal Stem Cells and Skews Their Differentiation Toward Goblet Cells.
     Gastroenterology. 2023;164:1137-1151.
     

     >> Share

     
     
126. ROSHANOV PS, Khanna R
     Continuation of Tumor Necrosis Factor Antagonists for Inflammatory Bowel Diseases During Pregnancy.
     Gastroenterology. 2023;164:1336-1337.
     

     >> Share

     
     
127. KILINCALP S, Mottacki N
     A Shallow Large Ulcer on the Ileocecal Valve in a Young Man With Ulcerative Proctitis.
     Gastroenterology. 2023;164:e16-e18.
     

     >> Share

     
     May 2023
128. RAYGOZA GARAY JA, Turpin W, Lee SH, Smith MI, et al
     Gut Microbiome Composition is associated with future onset of Crohn's Disease in Healthy First-Degree Relatives.
     Gastroenterology. 2023 May 30:S0016-5085(23)00805.
     

     >> Share

     
     
129. GHONEIM S
     Etrasimod in ulcerative colitis.
     Gastroenterology. 2023 May 11:S0016-5085(23)00725.
     

     >> Share

     
     
130. ARMSTRONG H, Sigall-Boneh R, Wine E
     This Letter to the Editor is in response to: Microbial Riboflavin Biosynthesis Associates with Response to Dietary Fiber Consumption: Time to Personalize Adjunct Therapy in Patients with Inflammatory Bowel Disease?
     Gastroenterology. 2023 May 5:S0016-5085(23)00700.
     

     >> Share

     
     
131. NEWMAN KL, Chedid VG, Boden EK
     A Systematic Review of Inflammatory Bowel Disease Epidemiology and Health Outcomes in Sexual and Gender Minority Individuals.
     Gastroenterology. 2023;164:866-871.
     

     >> Share

     
     April 2023
132. NOBLE AJ, Nowak JK, Adams AT, Uhlig HH, et al
     Defining interactions between the genome, epigenome, and the environment in inflammatory bowel disease: progress and prospects.
     Gastroenterology. 2023 Apr 14:S0016-5085(23)00619.
     

     >> Share

     
     
133. D'HAENS GR, Lee S, Taylor SA, Serone A, et al
     Filgotinib for the Treatment of Small Bowel Crohn's Disease: the DIVERGENCE 1 Trial.
     Gastroenterology. 2023 Apr 11:S0016-5085(23)00591.
     

     >> Share

     
     
134. ALLEGRETTI JR, Mitsialis V, Canavan JB, Snapper SB, et al
     Low-dose IL-2 for the Treatment of Moderate to Severe Ulcerative Colitis.
     Gastroenterology. 2023 Apr 6:S0016-5085(23)00584.
     

     >> Share

     
     
135. FRAISSENON A, Desmurs-Clavel H, Guibaud L
     Severe Chronic Rectocolitis Associated With a Characteristic Sunflower Magnetic Resonance Imaging Pattern.
     Gastroenterology. 2023;164:529-532.
     

     >> Share

     
     
136. GOWEN R, Gamal A, Di Martino L, McCormick TS, et al
     Modulating the Microbiome for Crohn's Disease Treatment.
     Gastroenterology. 2023;164:828-840.
     

     >> Share

     
     March 2023
137. KAPPELMAN MD, Wohl DA, Herfarth HH, Firestine AM, et al
     Comparative Effectiveness of Anti-TNF in Combination with Low Dose Methotrexate vs Anti-TNF Monotherapy in Pediatric Crohn's Disease: a Pragmatic Randomized Trial.
     Gastroenterology. 2023 Mar 31:S0016-5085(23)00538.
     

     >> Share

     
     
138. YANG Z, Qin J, Zhao L, Chen T, et al
     Host sorbitol and bacterial sorbitol utilization promote C. difficile infection in inflammatory bowel disease.
     Gastroenterology. 2023 Mar 8:S0016-5085(23)00238.
     

     >> Share

     
     
139. IACUCCI M, Parigi TL, Del Amor R, Meseguer P, et al
     Artificial Intelligence enabled histological prediction of remission or activity and clinical outcomes in ulcerative colitis.
     Gastroenterology. 2023 Mar 3:S0016-5085(23)00216.
     

     >> Share

     
     
140. NOVIELLO D, Facciotti F, Caprioli F
     Environmental Protective and Risk Factors in an At-Risk Population of Subsequent Crohn's Disease.
     Gastroenterology. 2023;164:500-501.
     

     >> Share

     
     

Free Medical Abstracts
Privacy Policy
Sponsors
Share